309 related articles for article (PubMed ID: 18036451)
1. Long-term use of sildenafil in the therapeutic management of heart failure.
Guazzi M; Samaja M; Arena R; Vicenzi M; Guazzi MD
J Am Coll Cardiol; 2007 Nov; 50(22):2136-44. PubMed ID: 18036451
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients.
Guazzi M; Casali M; Berti F; Rossoni G; Colonna VD; Guazzi MD
Clin Pharmacol Ther; 2008 Feb; 83(2):336-41. PubMed ID: 17653139
[TBL] [Abstract][Full Text] [Related]
3. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
5. Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes.
Aversa A; Vitale C; Volterrani M; Fabbri A; Spera G; Fini M; Rosano GM
Diabet Med; 2008 Jan; 25(1):37-44. PubMed ID: 18199130
[TBL] [Abstract][Full Text] [Related]
6. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.
Guazzi M; Tumminello G; Di Marco F; Fiorentini C; Guazzi MD
J Am Coll Cardiol; 2004 Dec; 44(12):2339-48. PubMed ID: 15607396
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study.
Guazzi M; Vicenzi M; Arena R
Eur J Heart Fail; 2012 Jan; 14(1):82-90. PubMed ID: 22067410
[TBL] [Abstract][Full Text] [Related]
8. Effects of sildenafil on cardiopulmonary responses during stress.
Stanopoulos I; Hatzichristou D; Tryfon S; Tzortzis V; Apostolidis A; Argyropoulou P
J Urol; 2003 Apr; 169(4):1417-21. PubMed ID: 12629375
[TBL] [Abstract][Full Text] [Related]
9. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
[TBL] [Abstract][Full Text] [Related]
11. Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure.
Guazzi M; Tumminello G; Di Marco F; Guazzi MD
Clin Pharmacol Ther; 2004 Oct; 76(4):371-8. PubMed ID: 15470337
[TBL] [Abstract][Full Text] [Related]
12. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.
Guazzi M; Vicenzi M; Arena R; Guazzi MD
Circ Heart Fail; 2011 Jan; 4(1):8-17. PubMed ID: 21036891
[TBL] [Abstract][Full Text] [Related]
13. The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men.
Dishy V; Sofowora G; Harris PA; Kandcer M; Zhan F; Wood AJ; Stein CM
Clin Pharmacol Ther; 2001 Sep; 70(3):270-9. PubMed ID: 11557915
[TBL] [Abstract][Full Text] [Related]
14. Treating heart failure with sildenafil.
Blum A
Congest Heart Fail; 2009; 15(4):181-5. PubMed ID: 19627292
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic sildenafil treatment on penile endothelial function: a randomized, double-blind, placebo controlled study.
Vardi Y; Appel B; Ofer Y; Greunwald I; Dayan L; Jacob G
J Urol; 2009 Dec; 182(6):2850-5. PubMed ID: 19837434
[TBL] [Abstract][Full Text] [Related]
16. Correlation between flow-mediated dilation and erectile dysfunction.
Kovács I; Császár A; Toth J; Siller G; Farkas A; Tarján J; Horváth J; Koller A
J Cardiovasc Pharmacol; 2008 Feb; 51(2):148-53. PubMed ID: 18287882
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of sildenafil on flow mediated dilatation and cardiovascular autonomic nerve function in type 2 diabetic patients.
Stirban A; Laude D; Elghozi JL; Sander D; Agelink MW; Hilz MJ; Ziegler D
Diabetes Metab Res Rev; 2009 Feb; 25(2):136-43. PubMed ID: 19116943
[TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
19. Type 5 phosphodiesterase inhibition by sildenafil abrogates acute smoking-induced endothelial dysfunction.
Vlachopoulos C; Tsekoura D; Alexopoulos N; Panagiotakos D; Aznaouridis K; Stefanadis C
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1040-4. PubMed ID: 15533731
[TBL] [Abstract][Full Text] [Related]
20. Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure.
Scott AC; Wensel R; Davos CH; Georgiadou P; Ceri Davies L; Coats AJ; Francis DP; Piepoli MF
Eur Heart J; 2004 Oct; 25(20):1806-13. PubMed ID: 15474695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
